Literature DB >> 15637653

Neurotoxicity of cancer chemotherapy.

Edward J Dropcho1.   

Abstract

Neurological dysfunction is a common side effect of many chemotherapy drugs. For several agents neurotoxicity is common, severe, and can be dose-limiting. This is a review of the clinical features of chemotherapy-induced syndromes involving the central and peripheral nervous systems.

Entities:  

Mesh：

Year:  2004        PMID： 15637653     DOI： 10.1055/s-2004-861536

Source DB:  PubMed          Journal:  Semin Neurol        ISSN： 0271-8235            Impact factor:   3.420


  6 in total

Review 1.  Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment.

Authors:  Gagandeep Singh; Jeremy H Rees; Josemir W Sander
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04       Impact factor: 10.154

2.  Barriers to pain assessment and management in cancer survivorship.

Authors:  Virginia Sun; Tami Borneman; Barbara Piper; Marianna Koczywas; Betty Ferrell
Journal:  J Cancer Surviv       Date:  2008-02-15       Impact factor: 4.442

3.  Developing central nervous system and vulnerability to platinum compounds.

Authors:  G Bernocchi; M G Bottone; V M Piccolini; V Dal Bo; G Santin; S A De Pascali; D Migoni; F P Fanizzi
Journal:  Chemother Res Pract       Date:  2011-02-15

4.  CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

Authors:  Joerg Dietrich; Ruolan Han; Yin Yang; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2006

5.  Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.

Authors:  Ruolan Han; Yin M Yang; Joerg Dietrich; Anne Luebke; Margot Mayer-Pröschel; Mark Noble
Journal:  J Biol       Date:  2008-04-22

Review 6.  Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide.

Authors:  Jungsil Ro; Fiona Tsui-Fen Cheng; Virote Sriuranpong; Antonio Villalon; B K Smruti; Janice Tsang; Yoon Sim Yap
Journal:  J Breast Cancer       Date:  2016-03-25       Impact factor: 3.588
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.